LRRK2 c.2728T>G ;(p.S910A)

Variant ID: 12-40687385-T-G

NM_198578.3(LRRK2):c.2728T>G;(p.S910A)

This variant was identified in 14 publications

View GRCh38 version.




Publications:


The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity.

The Journal Of Cell Biology
Stormo, Adrienne E D AED; Shavarebi, Farbod F; FitzGibbon, Molly M; Earley, Elizabeth M EM; Ahrendt, Hannah H; Lum, Lotus S LS; Verschueren, Erik E; Swaney, Danielle L DL; Skibinski, Gaia G; Ravisankar, Abinaya A; van Haren, Jeffrey J; Davis, Emily J EJ; Johnson, Jeffrey R JR; Von Dollen, John J; Balen, Carson C; Porath, Jacob J; Crosio, Claudia C; Mirescu, Christian C; Iaccarino, Ciro C; Dauer, William T WT; Nichols, R Jeremy RJ; Wittmann, Torsten T; Cox, Timothy C TC; Finkbeiner, Steve S; Krogan, Nevan J NJ; Oakes, Scott A SA; Hiniker, Annie A
Publication Date: 2022-04-04

Variant appearance in text: LRRK2: Ser910Ala
PubMed Link: 35266954
Variant Present in the following documents:
  • Main text
  • JCB_202010065.pdf
View BVdb publication page



Physiological and pathological functions of LRRK2: implications from substrate proteins.

Neuronal Signaling
Araki, Miho M; Ito, Genta G; Tomita, Taisuke T
Publication Date: 2018-12

Variant appearance in text: LRRK2: S910A
PubMed Link: 32714591
Variant Present in the following documents:
  • Main text
  • ns-02-ns20180005.pdf
View BVdb publication page



LRRK2 Phosphorylation, More Than an Epiphenomenon.

Frontiers In Neuroscience
Marchand, Antoine A; Drouyer, Matthieu M; Sarchione, Alessia A; Chartier-Harlin, Marie-Christine MC; Taymans, Jean-Marc JM
Publication Date: 2020

Variant appearance in text: LRRK2: S910A
PubMed Link: 32612495
Variant Present in the following documents:
  • Main text
View BVdb publication page



Guilt-by-Association - Functional Insights Gained From Studying the LRRK2 Interactome.

Frontiers In Neuroscience
Gloeckner, Christian Johannes CJ; Porras, Pablo P
Publication Date: 2020

Variant appearance in text: LRRK2: S910A
PubMed Link: 32508578
Variant Present in the following documents:
  • Main text
  • fnins-14-00485.pdf
View BVdb publication page



Inhibition of LRRK2 or Casein Kinase 1 Results in LRRK2 Protein Destabilization.

Molecular Neurobiology
De Wit, T T; Baekelandt, V V; Lobbestael, E E
Publication Date: 2019-08

Variant appearance in text: LRRK2: S910A
PubMed Link: 30592011
Variant Present in the following documents:
  • 12035_2018_Article_1449.pdf
View BVdb publication page



Nigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin mice.

Neurobiology Of Disease
Zhao, Ye Y; Keshiya, Shikara S; Atashrazm, Farzaneh F; Gao, Jianqun J; Ittner, Lars M LM; Alessi, Dario R DR; Halliday, Glenda M GM; Fu, Yuhong Y; Dzamko, Nicolas N
Publication Date: 2018-12

Variant appearance in text: LRRK2: S910A
PubMed Link: 30194047
Variant Present in the following documents:
  • Main text
View BVdb publication page



Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activity.

Npj Parkinson'S Disease
Kluss, Jillian H JH; Conti, Melissa M MM; Kaganovich, Alice A; Beilina, Aleksandra A; Melrose, Heather L HL; Cookson, Mark R MR; Mamais, Adamantios A
Publication Date: 2018

Variant appearance in text: LRRK2: S910A
PubMed Link: 29707617
Variant Present in the following documents:
  • Main text
  • 41531_2018_Article_49.pdf
View BVdb publication page



Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation.

Scientific Reports
Lobbestael, E E; Civiero, L L; De Wit, T T; Taymans, J-M JM; Greggio, E E; Baekelandt, V V
Publication Date: 2016-09-23

Variant appearance in text: LRRK2: S910A
PubMed Link: 27658356
Variant Present in the following documents:
  • Main text
  • srep33897.pdf
View BVdb publication page



Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors.

The Biochemical Journal
Ito, Genta G; Katsemonova, Kristina K; Tonelli, Francesca F; Lis, Pawel P; Baptista, Marco A S MA; Shpiro, Natalia N; Duddy, Graham G; Wilson, Steve S; Ho, Philip Wing-Lok PW; Ho, Shu-Leong SL; Reith, Alastair D AD; Alessi, Dario R DR
Publication Date: 2016-09-01

Variant appearance in text: LRRK2: S910A
PubMed Link: 27474410
Variant Present in the following documents:
  • Main text
  • bj4732671.pdf
View BVdb publication page



Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7.

Nature Communications
Chia, Ruth R; Haddock, Sara S; Beilina, Alexandra A; Rudenko, Iakov N IN; Mamais, Adamantios A; Kaganovich, Alice A; Li, Yan Y; Kumaran, Ravindran R; Nalls, Michael A MA; Cookson, Mark R MR
Publication Date: 2014-12-15

Variant appearance in text: LRRK2: S910A
PubMed Link: 25500533
Variant Present in the following documents:
  • Main text
  • NIHMS641836-supplement-1.pdf
  • nihms641836.pdf
View BVdb publication page



Arsenite stress down-regulates phosphorylation and 14-3-3 binding of leucine-rich repeat kinase 2 (LRRK2), promoting self-association and cellular redistribution.

The Journal Of Biological Chemistry
Mamais, Adamantios A; Chia, Ruth R; Beilina, Alexandra A; Hauser, David N DN; Hall, Christine C; Lewis, Patrick A PA; Cookson, Mark R MR; Bandopadhyay, Rina R
Publication Date: 2014-08-01

Variant appearance in text: LRRK2: S910A
PubMed Link: 24942733
Variant Present in the following documents:
  • Main text
  • zbc21386.pdf
View BVdb publication page



Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle.

The Biochemical Journal
Lobbestael, Evy E; Zhao, Jing J; Rudenko, Iakov N IN; Beylina, Aleksandra A; Gao, Fangye F; Wetter, Justin J; Beullens, Monique M; Bollen, Mathieu M; Cookson, Mark R MR; Baekelandt, Veerle V; Nichols, R Jeremy RJ; Taymans, Jean-Marc JM
Publication Date: 2013-11-15

Variant appearance in text: LRRK2: S910A
PubMed Link: 23937259
Variant Present in the following documents:
  • Main text
View BVdb publication page



Screening for novel LRRK2 inhibitors using a high-throughput TR-FRET cellular assay for LRRK2 Ser935 phosphorylation.

Plos One
Hermanson, Spencer B SB; Carlson, Coby B CB; Riddle, Steven M SM; Zhao, Jing J; Vogel, Kurt W KW; Nichols, R Jeremy RJ; Bi, Kun K
Publication Date: 2012

Variant appearance in text: LRRK2: Ser910Ala
PubMed Link: 22952710
Variant Present in the following documents:
  • Main text
  • pone.0043580.pdf
View BVdb publication page



14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization.

The Biochemical Journal
Nichols, R Jeremy RJ; Dzamko, Nicolas N; Morrice, Nicholas A NA; Campbell, David G DG; Deak, Maria M; Ordureau, Alban A; Macartney, Thomas T; Tong, Youren Y; Shen, Jie J; Prescott, Alan R AR; Alessi, Dario R DR
Publication Date: 2010-09-15

Variant appearance in text: LRRK2: S910A
PubMed Link: 20642453
Variant Present in the following documents:
  • Main text
  • bj4300393.pdf
View BVdb publication page